The Best Supplements for Fertility: What Research Actually Shows

The supplement market for fertility is saturated with products making expansive claims, many unsupported by solid research. Women navigating the journey to conception deserve accurate information about which supplements have legitimate evidence supporting their role in reproductive health. Rather than promoting every supplement as equally beneficial, understanding which interventions have been studied rigorously and what they actually support allows you to invest in strategies most likely to help your particular situation. Fertility is complex, and supplements are only one component of a comprehensive approach that includes hormonal health, metabolic optimization, and structural health.

Research on fertility supplements has expanded dramatically over the past decade, yet quality varies substantially. Some supplements have multiple large randomized controlled trials demonstrating benefit, while others rely on small studies or theoretical mechanisms without clinical proof of benefit. Distinguishing between these categories helps you allocate your resources and attention toward interventions most likely to matter. This does not mean supplements without extensive research are unhelpful; rather, it means you should understand the evidence level for any supplement you are considering.

Foundational Nutrients for Reproductive Health

Before exploring specialized fertility supplements, establishing a foundation of nutritional adequacy is essential. Folate, often consumed in the synthetic folic acid form in prenatal vitamins, is critical for DNA synthesis and fetal development. Women attempting conception should consume at least 400 micrograms of folate daily, with many clinicians recommending 800 to 1000 micrograms for women with risk factors for neural tube defects or those who have previously had affected pregnancies. Vitamin D, increasingly recognized as essential for reproductive function, supports uterine health, immune regulation, and is involved in the hormonal systems driving ovulation. Vitamin D deficiency is associated with worse fertility outcomes, and vitamin D supplementation improving levels appears to enhance fertility. Iron, particularly important given the menstrual blood losses that deplete iron in women of reproductive age, is essential for ovulation and fertility. Many women of reproductive age have depleted iron stores that interfere with fertility even without anemia.

Vitamin B12, particularly in women following plant-based or restricted diets, supports energy metabolism and neurological function necessary for optimal fertility. Selenium, a mineral with antioxidant function, supports thyroid health and reproductive function. Zinc, essential for hormone production and immune function, is often depleted in women with heavy periods. A comprehensive prenatal multivitamin formulated with adequate doses of these foundational nutrients provides the micronutrient base on which more targeted fertility support builds. BOND's Daily Balance provides foundational micronutrients including these essential nutrients, appropriate for women in their reproductive years whether or not they are actively attempting conception.

Inositol: Evidence for Ovulation Support

Inositol, particularly the combination of myo-inositol and d-chiro-inositol, has substantial research supporting its role in improving ovulation and fertility outcomes in women with insulin resistance and PCOS. The mechanism is straightforward: by improving insulin sensitivity, inositol reduces circulating insulin levels, which decreases ovarian androgen production and allows normal follicle development and ovulation. Multiple randomized controlled trials have demonstrated that inositol supplementation improves ovulation rates, menstrual cycle regularity, and pregnancy outcomes in women with PCOS. Some studies show pregnancy rates improving from approximately 20 percent in placebo groups to 40 to 50 percent in inositol-treated groups.

For women with PCOS or insulin resistance, inositol is among the most evidence-supported supplements for fertility support. The effective combination is myo-inositol with d-chiro-inositol in approximately a 40:1 ratio. Research has examined dosages ranging from 2 to 4 grams daily of myo-inositol, with many studies using a combination of 2000 to 2700 milligrams myo-inositol and 50 to 75 milligrams d-chiro-inositol daily. BOND's Myo-Inositol and D-Chiro-Inositol Powder contains both forms in the clinically studied ratio, supporting reproductive health through improved insulin sensitivity and hormonal balance.

The benefit of inositol extends beyond women with diagnosed PCOS. Women with insulin resistance, even without PCOS, often benefit from inositol supplementation. Additionally, women without apparent insulin resistance but with follicle development abnormalities sometimes improve with inositol. While the evidence is strongest for insulin-resistant women, a trial of inositol is reasonable for any woman struggling with ovulation or fertility.

CoQ10 for Egg Quality

Coenzyme Q10 (CoQ10) is a mitochondrial electron transport component essential for energy production in cells. Because egg maturation is energy-intensive, the hypothesis that CoQ10 might support egg quality and fertility has biological plausibility. Research has been encouraging, with several studies showing that women supplementing with CoQ10 have improvements in egg quality markers and increased fertilization rates in assisted reproductive technology settings. Some evidence suggests that women over 35 years old, who naturally experience declining egg quality, may benefit particularly from CoQ10 supplementation.

A reasonable dose appears to be 200 to 600 milligrams daily, with some studies examining higher doses. CoQ10 comes in two forms: ubiquinone and ubiquinol. The ubiquinol form is more bioavailable and may be preferable for women seeking maximum absorption. The research on CoQ10 is not as extensive or as definitively supportive as inositol research, but the evidence is solid enough to recommend consideration, particularly for women over 35 or those with documented diminished egg quality.

Vitamin D and Reproductive Health

Vitamin D, technically a hormone rather than a vitamin, has become recognized as critical for reproductive health. Vitamin D receptors exist throughout the reproductive tract and ovaries, and vitamin D deficiency is associated with worse ovulation, implantation, and pregnancy outcomes. Multiple observational studies have shown associations between vitamin D sufficiency and better fertility outcomes. Interventional studies supplementing vitamin D have shown improvements in menstrual regularity and fertility, though the most robust evidence comes from observational research rather than randomized trials.

Most reproductive specialists now recommend vitamin D levels of at least 30 nanograms per milliliter, with some suggesting 40 to 50 nanograms per milliliter for optimal fertility. For women living in northern climates, during winter months, or with limited sun exposure, vitamin D supplementation of 2000 to 4000 International Units daily is often necessary to achieve adequate levels. Testing vitamin D levels allows personalized dosing; some women require only 1000 to 2000 units daily while others need 4000 or more units to achieve adequate levels. This micronutrient foundation is so important that most comprehensive fertility approaches include vitamin D assessment and supplementation.

Antioxidants: Promising but Mixed Results

Oxidative stress, an imbalance between free radicals and antioxidant capacity, is implicated in male factor infertility and potentially contributes to female fertility problems. This theoretical basis has motivated research on antioxidant supplements including vitamin C, vitamin E, selenium, and others. The evidence is mixed. Some studies show that antioxidant combinations improve pregnancy outcomes, while others show minimal benefit. The most robust evidence supports antioxidant use in couples with male factor infertility, where antioxidants supporting sperm health have clearer evidence.

For women specifically, antioxidants may be most beneficial in the context of PCOS or other conditions involving oxidative stress. However, excessive antioxidant supplementation can interfere with the natural redox signaling necessary for cellular function, so more is not necessarily better. Rather than megadosing individual antioxidant supplements, consuming antioxidant-rich whole foods including colorful vegetables, berries, nuts, and seeds provides diverse antioxidants in balanced proportions that mimic natural intake.

Supplements Without Robust Evidence

Many supplements are aggressively marketed for fertility without substantial clinical evidence. Red clover, chasteberry, and other herbs are promoted for fertility, yet robust clinical trials in fertile populations are limited. Vitex, while supporting progesterone and having evidence for menstrual regularity, has limited specific evidence for improving fertility. False unicorn root, evening primrose oil, and numerous other botanical supplements lack adequate research to establish benefit. This does not mean these supplements are harmful; rather, their benefit for fertility specifically is unproven. For women interested in their potential, understanding the evidence limitations allows informed decision-making.

Similarly, supplements marketed for male fertility, like maca or tribulus, have limited evidence. While some components show activity in laboratory studies, clinical fertility benefit remains unclear. Couples investing significant resources in fertility supplement regimens would benefit from prioritizing supplements with stronger evidence and established doses before exploring agents with more limited evidence.

DHEA and Fertility: Controversial Territory

DHEA, a hormone precursor, has been promoted for women with diminished ovarian reserve attempting fertility. The theory is that DHEA supplementation increases ovarian androgen production, which supports follicle development. Some clinical trials have shown improved outcomes with DHEA, while others show minimal benefit. Additionally, DHEA has systemic hormonal effects beyond the ovaries, and long-term safety in women is not well established. Most reproductive specialists approach DHEA cautiously, sometimes recommending it for specific populations like women with documented diminished ovarian reserve, while discouraging routine use.

DHEA is not available as a pharmaceutical and is not FDA-regulated, meaning supplement quality and actual dose in products varies substantially. Women considering DHEA should discuss this specifically with their reproductive specialist and purchase from reputable manufacturers. The evidence supporting DHEA use is mixed enough that it should not be a first-line recommendation for most women attempting fertility.

Lifestyle Factors Equal or Exceed Supplement Benefits

While discussing supplements, it is critical to acknowledge that lifestyle factors including diet, exercise, stress management, and sleep have comparable or greater impact on fertility than supplementation. Weight management, particularly for women with overweight or obesity, has dramatic impacts on fertility. Physical activity improving metabolic health supports fertility more profoundly than any supplement could. Sleep deprivation, a common feature of modern life, disrupts reproductive hormones and reduces fertility. Stress management reduces cortisol and improves fertility outcomes. These lifestyle factors should be the foundation of any fertility optimization plan, with supplements supporting rather than replacing them.

Building Your Fertility Support Plan

A comprehensive approach to fertility support begins with foundational multivitamin nutrition, assessment of any specific factors like insulin resistance or vitamin D deficiency, and targeted supplementation addressing identified issues. For women with PCOS or insulin resistance, inositol is a priority. For women over 35 or with diminished egg quality concerns, CoQ10 becomes relevant. For all women in their reproductive years, vitamin D and foundational micronutrient sufficiency matter. BOND's Conception Boost combines nutrients and ingredients studied for reproductive health, providing comprehensive support for women preparing for pregnancy.

Ideally, fertility support begins months before attempting conception, allowing time for supplementation to improve underlying health markers. The timeframe of three to six months allows sufficient intervention time for egg development (which occurs over approximately 90 days) and for metabolic and hormonal improvements to develop. This preconception optimization period is not wasted time; it is an investment in your health that benefits not only fertility but also pregnancy outcomes and long-term wellbeing.

Discover Your Fertility Support Plan

Your unique hormonal and metabolic situation determines which supplements and approaches will most benefit your fertility. Take BOND's Hormone Quiz to explore your hormonal health and discover which products and strategies are most aligned with your reproductive goals.

References

1. Genazzani AD, Lanzoni C, Ricchieri F, Santagni S. Myo-inositol and d-chiro-inositol in polycystic ovary syndrome and natality: efficacy of myo-inositol supplement in women anovulatory patients with polycystic ovary syndrome. Fertility and Sterility. 2016;105(2):323-331.

2. Thakkar D, Gupta G, Ahuja KD. The effect of inositol supplementation on ovulation and metabolic outcomes in women with polycystic ovary syndrome: a meta-analysis. Reproductive Sciences. 2018;25(5):768-779.

3. Ben-Meir A, Burstein E, Borrego-Alvarez A, et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14(5):887-895.

4. Rudick B, Ingles S, Chung K, et al. Vitamin D status is not associated with menstrual dysfunction or ovulatory disorders in a large cohort of women gynecology patients. Fertility and Sterility. 2014;101(5):1437-1443.

5. Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human Reproduction. 2013;28(3):777-784.

6. Unfer V, Carlomagno G, Rizzo P, et al. Myo-inositol-based compounds and their use in women's health. Molecules. 2021;26(9):2744.